Hydroxypropyl methylcellulose acetate succinate: potential drug-excipient incompatibility

Area of Science:

• Pharmaceutical Sciences
• Materials Science
• Polymer Chemistry

Background:

• Hydroxypropyl methylcellulose acetate succinate (HPMC-AS) is a widely used pharmaceutical excipient.
• Understanding excipient stability and drug-excipient interactions is crucial for successful formulation development.
• Potential degradation pathways of HPMC-AS, particularly hydrolysis, need thorough investigation.

Purpose of the Study:

• To investigate the chemical stability of HPMC-AS under processing conditions.
• To evaluate the potential incompatibility between HPMC-AS and active pharmaceutical ingredients (APIs) with hydroxyl groups.
• To confirm the formation of degradation products and their reactivity with APIs.

Main Methods:

• Hot-melt extrusion (HME) was employed to prepare formulations of HPMC-AS with a model compound (compound A).
• Formulated products were subjected to accelerated heating conditions (140°C for up to 5 hours).
• Analysis of degradation products and esterification was performed using analytical techniques (e.g., chromatography, spectroscopy).

Main Results:

• Hydrolysis of HPMC-AS occurred under harsh processing conditions, generating succinic acid and acetic acid.
• Succinate esters of the model compound (compound A) and its epimer were identified in the HME product.
• Incompatibility was further confirmed through studies with dyphylline, indicating a general reactivity of HPMC-AS.

Conclusions:

• HPMC-AS can degrade to form acids that react with hydroxyl groups on APIs, leading to ester bond formation.
• This drug-excipient incompatibility poses a risk during pharmaceutical formulation, particularly under thermal stress.
• Careful consideration of HPMC-AS stability and potential reactivity is essential during drug product development to ensure formulation integrity.